Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Thrombosis and Haemostasis
|
September 1, 1996
Characterization of recombinant von Willebrand factors mutated on cysteine 509 or 695
V Siguret, A S Ribba, O Christophe, et al.
Annales De Biologie Clinique
|
October 19, 2005
[Plasma cell leukaemia]
C Rodriguez, J-C Pont, I Gouin-Thibault, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 11, 2012
Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients
F Z Smires, C Moreau, R Habbal, et al.
Thrombosis and Haemostasis
|
October 18, 1993
Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression
J M Lavergne, Y Piao, A S Ribba, et al.
European Review for Medical and Pharmacological Sciences
|
September 23, 2020
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications
S Voicu, M Delrue, B G Chousterman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 29, 2016
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin
I Gouin-Thibault, X Delavenne, A Blanchard, et al.
Annales Pharmaceutiques Francaises
|
July 7, 2014
[Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course]
O Conort, V Siguret, O Bourdon, et al.
La Revue De Medecine Interne
|
March 26, 2013
[Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists]
J P Cambus, D Magnin, C Ambid-Lacombe, et al.
Clinical Pharmacology and Therapeutics
|
October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients
E Pautas, C Moreau, I Gouin-Thibault, et al.
The British Journal of Dermatology
|
October 6, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak
L Frumholtz, J-D Bouaziz, M Battistella, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Thrombosis and Haemostasis
|
September 1, 1996
Characterization of recombinant von Willebrand factors mutated on cysteine 509 or 695
V Siguret, A S Ribba, O Christophe, et al.
Annales De Biologie Clinique
|
October 19, 2005
[Plasma cell leukaemia]
C Rodriguez, J-C Pont, I Gouin-Thibault, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 11, 2012
Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients
F Z Smires, C Moreau, R Habbal, et al.
Thrombosis and Haemostasis
|
October 18, 1993
Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression
J M Lavergne, Y Piao, A S Ribba, et al.
European Review for Medical and Pharmacological Sciences
|
September 23, 2020
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications
S Voicu, M Delrue, B G Chousterman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 29, 2016
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin
I Gouin-Thibault, X Delavenne, A Blanchard, et al.
Annales Pharmaceutiques Francaises
|
July 7, 2014
[Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course]
O Conort, V Siguret, O Bourdon, et al.
La Revue De Medecine Interne
|
March 26, 2013
[Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists]
J P Cambus, D Magnin, C Ambid-Lacombe, et al.
Clinical Pharmacology and Therapeutics
|
October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients
E Pautas, C Moreau, I Gouin-Thibault, et al.
The British Journal of Dermatology
|
October 6, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak
L Frumholtz, J-D Bouaziz, M Battistella, et al.
Page
of 5